GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Float Percentage Of Total Shares Outstanding

Palisade Bio (STU:7NS0) Float Percentage Of Total Shares Outstanding : 98.55% (As of Jun. 09, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Palisade Bio's float shares is 0.93 Mil. Palisade Bio's total shares outstanding is 0.94 Mil. Palisade Bio's float percentage of total shares outstanding is 98.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Palisade Bio's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Palisade Bio's Institutional Ownership is 0.35%.

Palisade Bio Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Palisade Bio's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.93/0.94
=98.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio (STU:7NS0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
NAVB TCON WINT SNGX XCUR RGBP TSOI FRTX HOTH THER OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
PALI:USA 7NS:Germany
Address
5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008
Website
https://www.palisadebio.com
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines